Skip to content

The study of fibroblasts iron death cause of diabetic nephropathy patients with renal anemia

The study of fibroblasts iron death cause of diabetic nephropathy patients with renal anemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200059617
Enrollment
Unknown
Registered
2022-05-04
Start date
2022-06-10
Completion date
Unknown
Last updated
2024-03-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic nephropathy renal anemia

Interventions

Sponsors

Shandong Province qianfoshan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 or above; 2. Diabetic nephropathy; 3. Generally in good condition, have a good understanding of their own illness and physical condition, have self-awareness, can communicate with people well; 4. Voluntarily participate in the study, understand the significance of the study and the indicators to be measured, and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Severe infection: fever, cough, phlegm, sore throat, abdominal pain, diarrhea, uncle furuncle and other skin and soft tissue infections, and routine blood white blood cell count exceeded the normal range (10×109/L); 2. Serious cardiovascular diseases, including chronic cardiac insufficiency of grade 3 or above and various heart rate disorders; 3. Infectious diseases: various hepatitis active stage, AIDS, syphilis, etc.; 4. Tumor evidence: certain tumor has been detected or clinical manifestations and tumor markers suggest the possibility of tumor; 5. The patient has severe cognitive impairment or is unwilling to participate; 6. The patient has neuromuscular disease, inflammatory bowel disease, and functional gastrointestinal disease

Design outcomes

Primary

MeasureTime frame
hemoglobin;

Countries

China

Contacts

Public ContactZunsong Wang

Shandong Province qianfoshan Hospital

wzsong3@163.com+86 15966608835

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026